Co-delivery of small interfering RNA and plasmid DNA using a polymeric vector incorporating endosomolytic oligomeric sulfonamide.
Co-delivery of small interfering RNA and plasmid DNA using a polymeric vector incorporating endosomolytic oligomeric sulfonamide.
复制标题
DOI:
10.1016/j.biomaterials.2011.03.042
复制
发表时间:
2011-07
期刊:
影响因子:
14
通讯作者:
Bae, You Han
中科院分区:
文献类型:
--
作者:
Kang, Han Chang;Bae, You Han
Cationic polymers are potential intracellular carriers for small interfering RNA (siRNA). The short and rigid nature of an siRNA chain often results in larger and more loosely packed particles compared to plasmid DNA (pDNA) after complexing with carrier polycations, and in turn, poor silencing effects are seen against the target mRNAs. A helper polyanion, pDNA, was incorporated along with siRNA to form compact nanosized polyplexes. At C/A (cation/anion) ratios of 2 and 5, poly(L-lysine) (PLL)/siRNA-pGFP and PLL/siRNA-pGFP-OSDZ (oligomeric sulfadiazine (OSDZ) for endosomolysis) complexes produced particles 90–150 nm in size with a 15–45 mV surface charge, while PLL/siRNA complexes yielded particles 1–2 μm in size at the same C/A ratios. The PLL/siRNA-pGFP (C/A 2) complexes showed significantly higher specific gene silencing (50–90% vs. 10–25%) than the complexes formed at C/A 5. PLL/siRNA-pGFP-OSDZ (C/A 2) complexes improved the specific gene silencing (90%) more dramatically than PLL/siRNA-pGFP (C/A 2) complexes (50%), demonstrating a potential role for OSDZ. PLL/siRNA-pGFP-OSDZ (C/A 2) complexes sustained higher specific gene silencing compared with PLL/siRNA-pGFP (C/A 2) complexes. Other oligomeric sulfonamides (OSA) with varying pKa used in PLL/siRNA-pGFP-OSA complexes also caused effective gene silencing. The pGFP in the PLL/siRNA-pGFP complexes successfully expressed GFP protein without interfering with the siRNA. In conclusion, this study demonstrates that long pDNA helps effectively form nanosized siRNA particles and that OSA enhances specific gene silencing. In a single nucleic acid carrier formulation, co-delivery of siRNA and pDNA is feasible to maximize therapeutic effects or to include therapeutic or diagnostic functionalities.
登录
查看更多内容
影响因子:
14
作者:
Kang, Han Chang;Kang, Ho-Jung;Bae, You Han
通讯作者:
Bae, You Han
影响因子:
10.8
作者:
Chono, Sumio;Li, Shyh-Dar;Conwell, Christine C.;Huang, Leaf
通讯作者:
Huang, Leaf
影响因子:
10.8
作者:
Gary, Dana J.;Puri, Nitin;Won, You-Yeon
通讯作者:
Won, You-Yeon
DOI:
10.1016/j.bbrc.2008.04.097
发表时间:
2008-08-01
影响因子:
3.1
作者:
Mukai, Hidefumi;Kawakami, Shigeru;Hashida, Mitsuru
通讯作者:
Hashida, Mitsuru
影响因子:
10.8
作者:
Fahrmeir, Julia;Gunther, Michael;Ogris, Manfred
通讯作者:
Ogris, Manfred